VERMONT COBRE: PROJECT 2: INNATE IMMUNE RESPONSES TO CRYPTOSPORIDIUM PARVUM
VERMONT COBRE: PROJECT 2: INNATE IMMUNE RESPONSES TO CRYPTOSPORIDIUM PARVUM
批准号:
7610751
负责人:
Beth Diane Kirkpatrick
金额:
$20.99万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2008-06-30
关键词:
AcuteAdultAntigensApoptosisBackBasic ScienceBiological AssayCell LineCellsChildChronicComputer Retrieval of Information on Scientific Projects DatabaseCountryCryptosporidiosisCryptosporidium parvumCytolysisDataEpithelial CellsEpitheliumFundingGrantHome environmentHomingImmuneImmune responseImmunologyIn VitroInfectionInflammatory disease of the intestineInstitutionIntestinal MucosaIntestinesKnowledgeLaboratoriesLeadLymphocyteMICA proteinMentorsMolecular GeneticsMucosal Immune ResponsesPeripheralPopulationPrevention therapyPropionibacterium acnesRecoveryResearchResearch PersonnelResearch ProposalsResourcesSourceStressT-Cell ReceptorT-LymphocyteTechniquesTherapeutic Corynebacterium ParvumUnited States National Institutes of HealthVermontcytotoxicityin vivoinvestigator trainingkillingsperforinprofessorreceptorresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Cryptosporidium parvum is an important global cause of persistent and chronic diarrhesa. In young children, particularly in underdeveloped countries, cryptosporidiosis is clinically more severe and is associated with more intestinal inflammation than infection in adults. Little is understood about the mucosal "innate" immune respone to C. parvum. Gamma delta (y6) T cells are an important T cell population in young children and in the intestinal tract. In response to infection at the intestine, T cells appear to expand in the periphery and
selectively "home" back to the intestinal mucosa, via gut-specific homing receptors (a4p7, aEp7). Intestinal yd T cells appear to modulate recovery of the epithelium, respond to intestinal "stress" and may have important cytolytic function, especially in killing of infected intestinal epithelial cells (and possibly CD4+ ap T
cells). This proposal seeks to train the investigator in classic and molecular/genetic immunology techniques and to apply this basic science knowledge to study mucosal immune responses to cryptosporidiosis in children, especially those in the developing world. The proposal hypotheses that \o T cells are important in the innate immune response to cryptosporidiosis, are activated in response to C. parvum via the T cell receptor with necessary co-stimulation by the gut-specific MHC-I molecule (MIC-A), and kill infected epithelial cells by cytolysis and apoptosis. This information will then be applied to the study of gamma delta T cells from a
small population of Bangladeshi children with acute cryptosporidiosis to demonstrate in vivo relevance. The primary mentor of this proposal is a full professor of Immunology with expertise in y6 T cells and with a laboratory skilled in the proposed research assays In the research proposal, Aim 1 establishes whether the activation of the y5 cells is via the TCR and requires co-stimulation with the MHC-I like molecule MIC-A. In this aim, cloned y and y chains of the T cell receptor
are transfected to a T cell receptor negative cell line and evaluated for function. Aim 2 evaluates the cytotoxicity of y5 via Fas-FasL and perforin and confirms whether cytotoxicity is antigen-dependent. Finally, to establish in vivo relevance, Aim 3 examines the y5 T cells from children with cryptosporidiosis, establishes whether these y6 cells (carrying gut homing receptors) can be extracted from peripheral
lymphocytes and if these clones have activation and cytolytic functions similar to the in vitro data. These data will advance our understanding of the mucosal immune response to cryptosporidiosis, which will lead to further advances in prevention and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
-
批准号:10219920
-
项目类别:
-
资助金额:$123.98万
-
财政年份:2019
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
-
批准号:10673589
-
项目类别:
-
资助金额:$124.94万
-
财政年份:2019
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Multi-Scale Modeling of SARS-CoV-2 Dissemination Dynamics
-
批准号:10402634
-
项目类别:
-
资助金额:$32.24万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
-
批准号:10021005
-
项目类别:
-
资助金额:$220.67万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Administrative Core
-
批准号:10706798
-
项目类别:
-
资助金额:$87.75万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Administrative Core
-
批准号:10898361
-
项目类别:
-
资助金额:$96.23万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Administrative Core
-
批准号:10021008
-
项目类别:
-
资助金额:$85.75万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Translational Global Infectious Diseases Research Center
-
批准号:10706797
-
项目类别:
-
资助金额:$228.75万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
-
批准号:10853787
-
项目类别:
-
资助金额:$96.23万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Administrative Core
-
批准号:10256813
-
项目类别:
-
资助金额:$71.09万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
-
批准号:10256812
-
项目类别:
-
资助金额:$165.82万
-
财政年份:2018
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
VERMONT COBRE: PROJECT 2: INNATE IMMUNE RESPONSES TO CRYPTOSPORIDIUM PARVUM
-
批准号:8360772
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2011
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
CAMPYLOBACTOR JEJUNI CHALLENGE MODEL DEVELOPMENT: DOSE-RANGING STUDY
-
批准号:8166976
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2010
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
CLINICAL TRIAL: PHASE I EVALUATION OF A LIVE ATTENUATED DEN4 VACCINE
-
批准号:8166998
-
项目类别:
-
资助金额:$49.21万
-
财政年份:2010
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
VERMONT COBRE: PROJECT 2: INNATE IMMUNE RESPONSES TO CRYPTOSPORIDIUM PARVUM
-
批准号:8167731
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2010
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
CAMPYLOBACTER JEJUNI CHALLENGE: ASSESSMENT OF HOMOLOGOUS PROTECTION
-
批准号:8166999
-
项目类别:
-
资助金额:$5.39万
-
财政年份:2010
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
VERMONT COBRE: PROJECT 2: INNATE IMMUNE RESPONSES TO CRYPTOSPORIDIUM PARVUM
-
批准号:7959817
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2009
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
CAMPYLOBACTOR JEJUNI CHALLENGE MODEL DEVELOPMENT: DOSE-RANGING STUDY
-
批准号:7952114
-
项目类别:
-
资助金额:$27.42万
-
财政年份:2009
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
VERMONT COBRE: PROJECT 2: INNATE IMMUNE RESPONSES TO CRYPTOSPORIDIUM PARVUM
-
批准号:7720916
-
项目类别:
-
资助金额:$17.39万
-
财政年份:2008
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
CAMPYLOBACTOR JEJUNI CHALLENGE MODEL DEVELOPMENT: DOSE-RANGING STUDY
-
批准号:7605828
-
项目类别:
-
资助金额:$1.37万
-
财政年份:2007
-
负责人:Beth Diane Kirkpatrick
-
依托单位:
海外基金